Due to the intense coverage of the prostatic specific antigen screening, prostate cancer has become one of the most frequently diagnosed cancers in western countries, over 90% of the patients being diagnosed in local or regional stages [1]. The gene discussed is KLK3; the disease is prostate carcinoma.